ResMed Inc
0KW4.L
$256.77 2.34%
Exchange: LSE | Sector: Healthcare | Industry: Medical Equipment Services
Q1 2025
Published: Oct 25, 2024

Earnings Highlights

  • Revenue of $1.22B up 27.2% year-over-year
  • EPS of $2.11 increased by 42.3% from previous year
  • Gross margin of 58.6%
  • Net income of 311.36M
  • ""Our focus on enhancing patient outcomes through technology is why we see less price sensitivity in our segments, leading to sustained demand despite challenging economic conditions."" - Mick Farrell, CEO
0KW4.L
ResMed Inc

Executive Summary

ResMed Inc (0KW4.L) reported a robust performance for Q1 2025, achieving a revenue of $1.22 billion, marking a year-over-year increase of 27.15%. This quarterly performance reflects the companyรขโ‚ฌโ„ขs continued focus on its core sectors รขโ‚ฌโ€œ Sleep and Respiratory Care and Software as a Service, adapting to evolving healthcare needs. Management has emphasized strategic investments into innovation as well as expanding their global footprint, majorly contributing to this success.

The net income surged to $311 million, a 41.90% increase compared to the previous year, underscoring effective operational efficiency and enhanced profitability. Managementรขโ‚ฌโ„ขs guidance suggests a positive outlook for the upcoming quarters, bolstered by new product releases and market expansions, which investors should watch closely.

Key Performance Indicators

Revenue
Increasing
1.22B
QoQ: 0.11% | YoY: 27.15%
Gross Profit
Increasing
717.22M
58.57% margin
QoQ: 1.84% | YoY: 19.52%
Operating Income
Increasing
387.31M
QoQ: 1.60% | YoY: 34.02%
Net Income
Increasing
311.36M
QoQ: 6.54% | YoY: 41.90%
EPS
Increasing
2.12
QoQ: 6.53% | YoY: 42.28%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 1,335.58 0.00 +9.1% View
Q4 2025 1,347.99 2.58 +10.2% View
Q3 2025 1,291.74 2.48 +7.9% View
Q2 2025 1,282.09 2.34 +10.3% View
Q1 2025 1,224.51 2.11 +27.2% View